{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:09:54Z","timestamp":1779023394000,"version":"3.51.4"},"reference-count":68,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":100,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.csbj.2022.04.011","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T02:30:12Z","timestamp":1650249012000},"page":"2070-2081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096"],"prefix":"10.34133","volume":"20","author":[{"given":"Daniele","family":"Veggi","sequence":"first","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Malito","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Lo Surdo","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Pansegrau","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Rippa","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newton","family":"Wahome","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Savino","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vega","family":"Masignani","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Bottomley","sequence":"additional","affiliation":[{"name":"GSK Vaccines srl, Via Fiorentina 1, Siena 53100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace D.","year":"2012","unstructured":"Pace D. and Pollard A.J.: Meningococcal disease: clinical presentation and sequelae. Vaccine 2012; 30: B3.","journal-title":"Vaccine"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_3_3_4_2","volume-title":"European Centre for Disease Prevention and Control. Invasive meningococcal diseaseECDC Annual Epidemiological Report","author":"ECDC","year":"2017","unstructured":"ECDC : European Centre for Disease Prevention and Control. Invasive meningococcal disease. ECDC Annual Epidemiological Report. : 2017."},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1586\/erv.09.18","article-title":"Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy","volume":"8","author":"Pace D.","year":"2009","unstructured":"Pace D.: Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy. Expert Rev Vaccines 2009; 8: 529.","journal-title":"Expert Rev Vaccines"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00554-5"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1016915"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.033"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4161\/hv.34293","article-title":"The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease","volume":"11","author":"Zlotnick G.W.","year":"2015","unstructured":"Zlotnick G.W., Jones T.R., Liberator P. et al: The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease. Hum Vaccin Immunother 2015; 11: 5.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C800214200"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M808831200"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07769"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.13793","article-title":"Meningococcal factor H-binding protein as immune evasion factor and vaccine antigen","author":"Principato S.","year":"2020","unstructured":"Principato S., Pizza M. and Rappuoli R.: Meningococcal factor H-binding protein as immune evasion factor and vaccine antigen. FEBS Lett. 2020; .","journal-title":"FEBS Lett."},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: Scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley K.A.","year":"2010","unstructured":"Jolley K.A. and Maiden M.C.: BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinform. 2010; 11: 595.","journal-title":"BMC Bioinform."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021911"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.4.2088-2100.2004"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1099\/mic.0.029876-0","article-title":"The modular architecture of meningococcal factor H-binding protein","volume":"155","author":"Beernink P.T.","year":"2009","unstructured":"Beernink P.T. and Granoff D.M.: The modular architecture of meningococcal factor H-binding protein. Microbiology 2009; 155: 2873.","journal-title":"Microbiology"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.027"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/21645515.2017.1264750","article-title":"Meningococcal serogroup B vaccines: Estimating breadth of coverage","volume":"13","author":"Donald R.G.","year":"2017","unstructured":"Donald R.G., Hawkins J.C., Hao L. et al: Meningococcal serogroup B vaccines: Estimating breadth of coverage. Hum Vaccin Immunother 2017; 13: 255.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"Frasch C.E.","year":"2009","unstructured":"Frasch C.E., Borrow R. and Donnelly J.: Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine 2009; 27: B112.","journal-title":"Vaccine"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00033-08"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00794-14"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","author":"Scarselli M.","year":"2011","unstructured":"Scarselli M., Arico B., Brunelli B. et al: Rational design of a meningococcal antigen inducing broad protective immunity. Sci Transl Med 2011; 3. 91ra62-91ra62.","journal-title":"Sci Transl Med"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.04.022"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2893"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-121217-094234"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101428","article-title":"Antibody-guided structure-based vaccines","volume":"50","author":"Kwong P.D.","year":"2020","unstructured":"Kwong P.D., DeKosky B.J. and Ulmer J.B.: Antibody-guided structure-based vaccines. Semin. Immunol. 2020; 50.","journal-title":"Semin. Immunol."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151960"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.molimm.2009.02.021","article-title":"A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups","volume":"46","author":"Beernink P.T.","year":"2009","unstructured":"Beernink P.T., LoPasso C., Angiolillo A., Felici F. and Granoff D.: A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol Immunol 2009; 46: 1647.","journal-title":"Mol Immunol"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047973","article-title":"Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis","volume":"7","author":"Piet J.R.","year":"2012","unstructured":"Piet J.R., Brouwer M.C., Exley R., van der Veen S., van de Beek D. and van der Ende A.: Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis. PLoS ONE 2012; 7: e47973.","journal-title":"PLoS ONE"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies","volume":"79","author":"Seib K.L.","year":"2011","unstructured":"Seib K.L., Brunelli B., Brogioni B. et al: Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun 2011; 79: 970.","journal-title":"Infect Immun"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243283"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1306441"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002981"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1222845110"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1507829112"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01491-15"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb1203-980"},{"key":"e_1_3_3_39_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy E.","year":"2009","unstructured":"Murphy E., Andrew L., Lee K.L. et al: Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis 2009; 200: 379.","journal-title":"J Infect Dis"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.05.022"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41467-018-02827-7","article-title":"Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp","volume":"9","author":"Lopez-Sagaseta J.","year":"2018","unstructured":"Lopez-Sagaseta J., Beernink P.T., Bianchi F. et al: Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp. Nat Commun. 2018; 9: 528.","journal-title":"Nat Commun."},{"key":"e_1_3_3_42_2","article-title":"Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6","author":"Bianchi F.","year":"2019","unstructured":"Bianchi F., Veggi D., Santini L. et al: Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6. FASEB J. 2019; . fj201900374R.","journal-title":"FASEB J."},{"key":"e_1_3_3_43_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008882","article-title":"4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp","volume":"16","author":"Veggi D.","year":"2020","unstructured":"Veggi D., Bianchi F., Santini L. et al: 4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp. PLoS Pathog 2020; 16: e1008882.","journal-title":"PLoS Pathog"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2013.08.005"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003470"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.vaccine.2013.08.099","article-title":"Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice","volume":"31","author":"Rossi R.","year":"2013","unstructured":"Rossi R., Granoff D.M. and Beernink P.T.: Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice. Vaccine 2013; 31: 5451.","journal-title":"Vaccine"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/IAI.01183-13","article-title":"Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates","volume":"82","author":"van der Veen S.","year":"2014","unstructured":"van der Veen S., Johnson S., Jongerius I. et al: Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates. Infect Immun 2014; 82: 1157.","journal-title":"Infect Immun"},{"key":"e_1_3_3_48_2","doi-asserted-by":"crossref","first-page":"e01625","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa I.","year":"2014","unstructured":"Costa I., Pajon R. and Granoff D.M.: Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding. MBio 2014; 5: e01625.","journal-title":"MBio"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00260-13"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00103-12"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003528"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi301161w"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav9033"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160613106"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2020.00283","article-title":"Designs of antigen structure and composition for improved protein-based vaccine efficacy","volume":"11","author":"Saylor K.","year":"2020","unstructured":"Saylor K., Gillam F., Lohneis T. and Zhang C.: Designs of antigen structure and composition for improved protein-based vaccine efficacy. Front Immunol 2020; 11: 283.","journal-title":"Front Immunol"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq085"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.10.003"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-196-3_6"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005557"},{"key":"e_1_3_3_60_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Xds K.W.","year":"2010","unstructured":"Xds K.W.: Acta Crystallogr D Biol Crystallogr 2010; 66: 125.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444913000061"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910045749"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889807021206"},{"key":"e_1_3_3_64_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1107\/S1744309111006154","article-title":"Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086)","volume":"67","author":"Cendron L.","year":"2011","unstructured":"Cendron L., Veggi D., Girardi E. and Zanotti G.: Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086). Acta Crystallogr Sect F Struct Biol Cryst Commun 2011; 67: 531.","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910007493"},{"key":"e_1_3_3_66_2","doi-asserted-by":"crossref","unstructured":"Afonine PV Grosse-Kunstleve RW Echols N et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr. Apr 2012;68(Pt 4):352-67. doi:10.1107\/S0907444912001308.","DOI":"10.1107\/S0907444912001308"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3235"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.181342398"},{"key":"e_1_3_3_69_2","unstructured":"Molecular Operating Environment (MOE). 2019."}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2022.04.011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:59:40Z","timestamp":1779022780000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2022.04.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":68,"alternative-id":["10.1016\/j.csbj.2022.04.011"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2022.04.011","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2022.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}